Thomas Radimerski;Patrick Chene;Carlos Garcia-Echeverria;Michael Rugaard Jensen;Cornelia Quadt;Joseph Schoepfer
发明人:
Patrick Chene,Carlos Garcia-Echeverria,Michael Rugaard Jensen,Cornelia Quadt,Thomas Radimerski,Joseph Schoepfer
申请号：
US14925263
公开号：
US20160045513A1
申请日:
2015.10.28
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The use of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide or a tautomer thereof or a pharmaceutically acceptable salt or a hydrate or a solvate for the treatment of cancer of the bladder, the colon, the liver, the lung, the breast, the vagina, the ovaries, the pancreas, the kidney, the stomach, the gastrointestinal tract, the prostate, the head and neck, the peritoneal cavity, the thyroid, the bone, the brain, the central nervous system and/or the blood and/or for the treatment of myelodysplastic syndrome, systemic mastocytosis, von Hippel-Lindau syndrome, multicentric Castleman disease and/or psioriasis.
